PharmaBlock Sciences (Nanjing), Inc. products

Fragment Based Drug Discovery (FBDD) has been established as an efficient tool in search of more accessible drug-like chemical space. Our FBDD group has developed a unique and well-designed fragment library with superb structural novelty and diversity based on our building block collections. Accompanied by our state-of-the-art screening platform equipped with various cutting-edge biophysical and biochemical screening technologies, our FBDD platform is capable of efficiently discovering novel fragment hits with optimum physicochemical properties. Continuous hit and lead generation from fragment hits are usually carried out by rational design based on structure information from our structural biology team. The FBDD service at PharmaBlock is committed to providing effective and high-quality drug discovery solutions to clients.